Skip to main content
Journal cover image

SFBTMGMB (N-succinimidyl 3-((4-(4-fluorobutyl)-1H-1,2,3-triazol-1-yl)methyl)-5-(guanidinomethyl)benzoate): An SGMIB analogue for labeling internalizing biomolecules with F-18

Publication ,  Journal Article
Vaidyanathan, G; McDougald, D; Pruszynski, M; Koumarianou, E; Hens, MA; Lahoutte, T; Zalutsky, MR
Published in: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
May 1, 2013

Duke Scholars

Published In

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

ISSN

0362-4803

Publication Date

May 1, 2013

Volume

56

Start / End Page

S127 / S127

Publisher

WILEY-BLACKWELL

Related Subject Headings

  • Medicinal & Biomolecular Chemistry
  • 3405 Organic chemistry
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 0305 Organic Chemistry
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vaidyanathan, G., McDougald, D., Pruszynski, M., Koumarianou, E., Hens, M. A., Lahoutte, T., & Zalutsky, M. R. (2013). SFBTMGMB (N-succinimidyl 3-((4-(4-fluorobutyl)-1H-1,2,3-triazol-1-yl)methyl)-5-(guanidinomethyl)benzoate): An SGMIB analogue for labeling internalizing biomolecules with F-18. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 56, S127–S127.
Vaidyanathan, Ganesan, Darryl McDougald, Marek Pruszynski, Eftychia Koumarianou, Marc Anton Hens, Tony Lahoutte, and Michael Rod Zalutsky. “SFBTMGMB (N-succinimidyl 3-((4-(4-fluorobutyl)-1H-1,2,3-triazol-1-yl)methyl)-5-(guanidinomethyl)benzoate): An SGMIB analogue for labeling internalizing biomolecules with F-18.” JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 56 (May 1, 2013): S127–S127.
Vaidyanathan G, McDougald D, Pruszynski M, Koumarianou E, Hens MA, Lahoutte T, et al. SFBTMGMB (N-succinimidyl 3-((4-(4-fluorobutyl)-1H-1,2,3-triazol-1-yl)methyl)-5-(guanidinomethyl)benzoate): An SGMIB analogue for labeling internalizing biomolecules with F-18. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2013 May 1;56:S127–S127.
Vaidyanathan, Ganesan, et al. “SFBTMGMB (N-succinimidyl 3-((4-(4-fluorobutyl)-1H-1,2,3-triazol-1-yl)methyl)-5-(guanidinomethyl)benzoate): An SGMIB analogue for labeling internalizing biomolecules with F-18.” JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 56, WILEY-BLACKWELL, May 2013, pp. S127–S127.
Vaidyanathan G, McDougald D, Pruszynski M, Koumarianou E, Hens MA, Lahoutte T, Zalutsky MR. SFBTMGMB (N-succinimidyl 3-((4-(4-fluorobutyl)-1H-1,2,3-triazol-1-yl)methyl)-5-(guanidinomethyl)benzoate): An SGMIB analogue for labeling internalizing biomolecules with F-18. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. WILEY-BLACKWELL; 2013 May 1;56:S127–S127.
Journal cover image

Published In

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

ISSN

0362-4803

Publication Date

May 1, 2013

Volume

56

Start / End Page

S127 / S127

Publisher

WILEY-BLACKWELL

Related Subject Headings

  • Medicinal & Biomolecular Chemistry
  • 3405 Organic chemistry
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 0305 Organic Chemistry